As per the research report, the size of the APAC Nucleic Acid isolation and Purification Market was valued at USD 0.57 billion in 2023 and is expected to reach USD 0.90 billion b 2028, increasing at a CAGR of 9.54% during the forecast period 2023 to 2028.
In molecular biology and recombinant DNA procedures, extraction and purification of nucleic acids is a crucial step. Thus, a set of molecular biology techniques for extracting and purifying DNA and RNA in downstream applications is known as nucleic acid isolation and purification.
This method has numerous life science research, genetic engineering, forensics, and molecular diagnostics applications. Nucleic acid isolation speeds up sample processing, reduces nucleic acid loss and degradation, and improves laboratory efficiency and efficacy. As a result, the purified product can be used in recombinant technology processes and for specific research goals.
The cost of genetic sequencing is decreasing; enhanced technologies in genetics development and the adoption of customized medicine and diagnostics are some of the drivers driving market expansion. Furthermore, discovering new pharmaceuticals, mergers, acquisitions, and partnerships contribute to the market's growth. In addition, the automation of products has increased the use of nucleic acid molecular diagnostics and market growth.
Growing worker safety, reproducibility, timeliness, and accuracy outcomes are vital in the possibility of laboratory efficiency, which has propelled market expansion. In addition, the increasing need for manufacturing aids in the development of nucleic acid-based goods such as DNA vaccines and double-stranded RNA non-coding molecules has increased nucleic acid isolation and purification, which is likely to fuel market growth.
Low penetration of equipment for nucleic acid and isolation purification procedures in current countries and an increase in the number of processes that strengthen the markets are some factors that limit the market growth.
The expenses connected with the instruments are pretty high, to the point where many people cannot afford treatment, and a rise in government funding for research and development activities are two main obstacles impeding market expansion. The high cost of automated instruments, on the other hand, is projected to stifle industry expansion.
This research report on the Asia Pacific Nucleic Acid Isolation and Purification Market have been segmented and sub-segmented into the following categories.
By End User:
Geographically, the nucleic acid isolation and purification market in APAC region is predicted to grow significantly over the forecast period, with substantial potential in the nucleic acid isolation and purification industry. The rise in this region might be attributable to several rising economies raising knowledge about the use of nucleic acid in various industries. However, due to a substantial increase in DNA or RNA libraries for NGS, China is expected to hold the most significant market share.
Factors such as rising demography and increasing economies in India's nucleic acid isolation and purification market is expected to drive market expansion in this area. In addition, because of the growing number of genomic projects in countries like China and India, the APAC nucleic acid isolation and purification market is expected to increase significantly.
The China nucleic acid isolation and purification market held the largest share of the market globally over the forecast period. Technological advancements in the healthcare sector, the rising number of genomic projects, and nucleic acid use drive market growth.
It is expected that the growing number of research and development investments by pharmaceutical and biotechnology businesses will have fueled the expansion of the nucleic acid isolation and purification market in the area.
KEY MARKET PLAYERS
Companies dominating the Asia Pacific Nucleic acid isolation and purification market Profiled in the Report are Qiagen, Bio-Rad Laboratories Inc, Illumina Inc, Agilent Technologies Inc, Thermo Fischer Scientific Inc, F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, General Electric Company, Danaher Corporation, Promega Corporation, Life Technologies, Roche Applied Sciences, Takara Bio, Inc., etc.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com